Tag Archives: Gene Patents

Tomorrow: BIO is “To the Point” on Gene Patenting

BIO is participating in an NPR segment at approximately 2:08pm ET tomorrow on the nationally-syndicated national radio program “To the Point” which originates in NYC. It should air on WAMU in DC, too, for those of you in the Nation’s capital.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Tomorrow Morning on NPR: BIO, ACLU Discuss Gene Patenting

You can listen from your desk at http://www.wbur.org/listen. Callers will have the opportunity to ask questions after the first 20 minutes. If you’re interested in the topic, you can find background material on gene patenting at http://bio.org/ip/genepat/ and our amicus brief in the ACLU lawsuit is posted at http://bio.org/ip/amicus/documents/BIOAmicusBriefACLU-Myriad12-09.pdf.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Department of State: Foster Climate Change Solutions, Biodiversity, & Economic Development with IPR Protections

CropLife has recently published their newest video interview last week with Carrie LaCrosse, of the Office of Intellectual Property Enforcement at the U.S. Department of State. LaCrosse discusses the value of IP for agriculture, looking in particular at new plant varieties and how IP is part of the solution in addressing the issues of food security.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO to USA Today: Patents Promote Innovation

Public debate over access to, and use of, genetic technology is a good thing. It requires the consideration of many factors, including coverage and cost, concerns over genetic discrimination and myriad regulatory issues.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Patent Docs: Falsehoods, Distortions and Outright Lies in the Gene Patenting Debate

Patent Docs blog reviewed the most repeated criticisms of the patenting of genetic materials, providing a critical hand to assist non-technical observers of the debate currently swirling around in legal, scientific, and academic circles.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,